Methods of using APO2l receptor agonists and NK cell activators

Details for Australian Patent Application No. 2005264993 (hide)

Owner Genentech, Inc.

Inventors Satyal, Sanjeev H.; Godowski, Paul J.

Agent Griffith Hack

Pub. Number AU-A-2005264993

PCT Pub. Number WO2006/009731

Priority 60/581,129 18.06.04 US

Filing date 15 June 2005

Wipo publication date 26 January 2006

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2006/009731 Priority application(s): WO2006/009731

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005264996-Gonadotropin releasing hormone receptor antagonists

2005264990-A system for automatically locating and manipulating positions on an object